For four days, from May 12 to 15, the Research Institute of Molecular Pathology (IMP) in Vienna will host the EMBO-Workshop “SMC proteins – Chromosomal organizers from bacteria to human“.
The scientific meeting, jointly organised by the IMP and EMBO (the European Molecular Biology Organization), draws the world’s leading experts on SMC proteins to the IMP at the Vienna Biocenter.
For the first time, the topic will be highlighted to such an extent, with talks and discussions spanning the entire spectrum from pure basic research to future therapeutic concepts for human medicine.
Proteins of the SMC (Structural Maintenance of Chromosomes)-family are one of the most fundamental classes of chromosomal organizers and are found in all organisms, from bacteria to humans. They are involved in a wide variety of chromosomal processes, including cell division, DNA repair and gene regulation.
Just how essential SMC proteins are to all living beings is underpinned by the fact that their mode of action is virtually identical when simple life-forms such as yeast are compared to human cells. (Baker’s yeast is therefore a popular model organism for scientists studying SMC proteins).
Their universality also means that dysfunctional SMC proteins may bear serious consequences: they have been linked to human developmental syndromes and mutations in SMC proteins are frequently seen in certain types of cancer. Life scientists from the fields of structural biology to human genetics are therefore interested in understanding how SMC proteins work and how exactly their failure is linked to human disease.
The first SMC-complexes were identified and described about 20 years ago. Pioneering research was carried out at the IMP in Vienna by Kim Nasmyth, the institute’s director from 1997 to 2006. Together with Doug Koshland in the USA, he discovered the cohesin-complex in the yeast Saccharomyces cerevisiae. Jan-Michael Peters, scientific director of the IMP since 2013, has been studying cohesin in human cells for many years.
This long-standing focus makes the IMP an ideal meeting-point for leading experts in the area of SMC proteins. Openings for the workshop filled up fast and around 140 researchers – from New Zealand to Canada – are expected at the IMP over the next four days.
Among them are Kim Nasmyth (University of Oxford), Doug Koshland (University of California, Berkeley), Mitsuhiro Yanagida (Okinawa Institute of Science and Technology) Frank Uhlmann (Crick Institute, London), Jan Löwe (MRC Lab of Molecular Biology, Cambridge), David Sherratt (Department of Biochemistry, University of Oxford), Barbara Meyer (Berkeley), Yoshinori Watanabe, Katsu Shirahige (Tokyo University), Xiaolan Zhao (Memorial Sloan Kettering Cancer Center, New York), and Tatsuya Hirano (RIKEN Institute, Japan).
The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 35 nations, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, neurobiology, disease mechanisms and computational biology. The IMP is a founding member of the Vienna Biocenter, Austria’s flagship location in the global arena of cutting-edge research in molecular biology.
The European Molecular Biology Organization (EMBO) is an organization of more than 1,700 leading researchers that promotes excellence in the life sciences. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, and help build a European research environment where scientists can achieve their best work.”
T: +43 1 79730 3627
M: +43 664 80847 3627
T: +43 1 79730 3625
M: +43 664 8247910
Dr. Heidemarie Hurtl | idw - Informationsdienst Wissenschaft
Virtual Worlds: Research Trends in Mobile 3D Data Collection
30.11.2016 | Fraunhofer IPM
4th UKP-Workshop 2017 – Save the Date!
15.09.2016 | Fraunhofer-Institut für Lasertechnik ILT
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Life Sciences
08.12.2016 | Physics and Astronomy
08.12.2016 | Materials Sciences